A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates.
Researchers at UT Southwestern Medical Centre used ChatGPT to assess whether patients were eligible to take part in clinical trials and were able to identify suitable candidates within minutes.
Clinical trials, which test new medications and procedures on the public, are vital for developing and validating new treatments. But many trials struggle to enrol enough participants. According to a recent study, up to 20% of National Cancer Institute (NCI)-affiliated trials fail due to low enrolment. This not only inflates costs and delays results, but also undermines the reliability of new treatments.
Currently, screening patients for trials is a manual process. Researchers must review each patient’s medical records to determine if they meet eligibility criteria, which takes around 40 minutes per patient. With limited staff and resources, this process is often too slow to keep up with demand.
Part of the problem is that valuable patient information contained in electronic health records (EHRs) is often buried in unstructured text, such as doctors’ notes, which traditional machine learning software struggles to decipher. As a result, many eligible patients are overlooked because there simply isn’t enough capacity to review every case. This contributes to low enrolment rates, trial delays and even cancellations, ultimately slowing down access to new therapies.
To counter this problem, the researchers have looked at ways of speeding up the screening process by using ChatGPT. Researchers used GPT-3.5 and GPT-4 to analyse 74 patients’ data to see if they qualified for a head and neck cancer trial.
Three ways of prompting the AI were tested:
- Structured Output (SO): asking for answers in a set format.
- Chain of Thought (CoT): asking the model to explain its reasoning.
- Self-Discover (SD): letting the model figure out what to look for.
The results were promising. GPT-4 was more accurate than GPT-3.5, though slightly slower and more expensive. Screening times ranged from 1.4 to 12.4 minutes per patient, with costs between $0.02 and $0.27.
LLMs like GPT-4 can help screen patients for clinical trials, especially when using flexible criteria. They’re not perfect, especially when all rules must be met, but they can save time and support human reviewers.”
Dr. Mike Dohopolski, lead author of the study
This research highlights the potential for AI to support faster, more efficient clinical trials – bringing new treatments to patients sooner.
The study is one of the first articles published in IOP Publishing’s Machine Learning series™, the world’s first open access journal series dedicated to the application and development of machine learning (ML) and artificial intelligence (AI) for the sciences.
The same research team have worked on a method that allows surgeons to adjust patients’ radiation therapy in real time whilst they are still on the table. Using a deep learning system called GeoDL, the AI delivers precise 3D dose estimates from CT scans and treatment data in just 35 milliseconds. This could make adaptive radiotherapy faster and more efficient in real clinical settings.
Beattie, J., et al. (2025). ChatGPT augmented clinical trial screening. Machine Learning: Health. doi.org/10.1088/3049-477x/adbd47.
News
Fever-Proof Bird Flu Variant Could Fuel the Next Pandemic
Bird flu viruses present a significant risk to humans because they can continue replicating at temperatures higher than a typical fever. Fever is one of the body’s main tools for slowing or stopping viral [...]
What could the future of nanoscience look like?
Society has a lot to thank for nanoscience. From improved health monitoring to reducing the size of electronics, scientists’ ability to delve deeper and better understand chemistry at the nanoscale has opened up numerous [...]
Scientists Melt Cancer’s Hidden “Power Hubs” and Stop Tumor Growth
Researchers discovered that in a rare kidney cancer, RNA builds droplet-like hubs that act as growth control centers inside tumor cells. By engineering a molecular switch to dissolve these hubs, they were able to halt cancer [...]
Platelet-inspired nanoparticles could improve treatment of inflammatory diseases
Scientists have developed platelet-inspired nanoparticles that deliver anti-inflammatory drugs directly to brain-computer interface implants, doubling their effectiveness. Scientists have found a way to improve the performance of brain-computer interface (BCI) electrodes by delivering anti-inflammatory drugs directly [...]
After 150 years, a new chapter in cancer therapy is finally beginning
For decades, researchers have been looking for ways to destroy cancer cells in a targeted manner without further weakening the body. But for many patients whose immune system is severely impaired by chemotherapy or radiation, [...]
Older chemical libraries show promise for fighting resistant strains of COVID-19 virus
SARS‑CoV‑2, the virus that causes COVID-19, continues to mutate, with some newer strains becoming less responsive to current antiviral treatments like Paxlovid. Now, University of California San Diego scientists and an international team of [...]
Lower doses of immunotherapy for skin cancer give better results, study suggests
According to a new study, lower doses of approved immunotherapy for malignant melanoma can give better results against tumors, while reducing side effects. This is reported by researchers at Karolinska Institutet in the Journal of the National [...]
Researchers highlight five pathways through which microplastics can harm the brain
Microplastics could be fueling neurodegenerative diseases like Alzheimer's and Parkinson's, with a new study highlighting five ways microplastics can trigger inflammation and damage in the brain. More than 57 million people live with dementia, [...]
Tiny Metal Nanodots Obliterate Cancer Cells While Largely Sparing Healthy Tissue
Scientists have developed tiny metal-oxide particles that push cancer cells past their stress limits while sparing healthy tissue. An international team led by RMIT University has developed tiny particles called nanodots, crafted from a metallic compound, [...]
Gold Nanoclusters Could Supercharge Quantum Computers
Researchers found that gold “super atoms” can behave like the atoms in top-tier quantum systems—only far easier to scale. These tiny clusters can be customized at the molecular level, offering a powerful, tunable foundation [...]
A single shot of HPV vaccine may be enough to fight cervical cancer, study finds
WASHINGTON -- A single HPV vaccination appears just as effective as two doses at preventing the viral infection that causes cervical cancer, researchers reported Wednesday. HPV, or human papillomavirus, is very common and spread [...]
New technique overcomes technological barrier in 3D brain imaging
Scientists at the Swiss Light Source SLS have succeeded in mapping a piece of brain tissue in 3D at unprecedented resolution using X-rays, non-destructively. The breakthrough overcomes a long-standing technological barrier that had limited [...]
Scientists Uncover Hidden Blood Pattern in Long COVID
Researchers found persistent microclot and NET structures in Long COVID blood that may explain long-lasting symptoms. Researchers examining Long COVID have identified a structural connection between circulating microclots and neutrophil extracellular traps (NETs). The [...]
This Cellular Trick Helps Cancer Spread, but Could Also Stop It
Groups of normal cbiells can sense far into their surroundings, helping explain cancer cell migration. Understanding this ability could lead to new ways to limit tumor spread. The tale of the princess and the [...]
New mRNA therapy targets drug-resistant pneumonia
Bacteria that multiply on surfaces are a major headache in health care when they gain a foothold on, for example, implants or in catheters. Researchers at Chalmers University of Technology in Sweden have found [...]
Current Heart Health Guidelines Are Failing To Catch a Deadly Genetic Killer
New research reveals that standard screening misses most people with a common inherited cholesterol disorder. A Mayo Clinic study reports that current genetic screening guidelines overlook most people who have familial hypercholesterolemia, an inherited disorder that [...]
